Abbott Runs Into FDA Buzzsaw, Faces Major Marketplace Crisis

BY NOW, MOST OF THE clinical laboratory industry knows that Abbott Laboratories, Inc. signed a consent decree with the Food and Drug Administration (FDA) on November 2, 1999. Under terms of the consent decree, Abbott paid a $100 million fine and will pull a number of test kits out of the marketplace. The original date […]

To access this post, you must purchase The Dark Report.

Abbott Runs Into FDA Buzzsaw, Faces Major Marketplace Crisis

Second largest diagnostics manufacturer forced to pull a multitude of lab test products

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month